- Parasites and Host Interactions
- Helminth infection and control
- Parasite Biology and Host Interactions
- Research on Leishmaniasis Studies
- Malaria Research and Control
- Parasitic Diseases Research and Treatment
- Global Maternal and Child Health
- Child Nutrition and Water Access
- Parasitic Infections and Diagnostics
- Mosquito-borne diseases and control
- Crystallization and Solubility Studies
- X-ray Diffraction in Crystallography
- Coccidia and coccidiosis research
- Trypanosoma species research and implications
- Pharmacological Effects and Toxicity Studies
- Insect Pest Control Strategies
- Metabolomics and Mass Spectrometry Studies
- Pneumocystis jirovecii pneumonia detection and treatment
- Zoonotic diseases and public health
- Gut microbiota and health
- Trace Elements in Health
- Drug-Induced Hepatotoxicity and Protection
- Parasitic infections in humans and animals
- Ferrocene Chemistry and Applications
- Dermatological diseases and infestations
Swiss Tropical and Public Health Institute
2016-2025
University of Basel
2016-2025
University Hospital of Basel
2024
Swiss School of Public Health
2024
University of Ghana
2023
University of California, Berkeley
2022
Health Net
2015
Ministry of Health
2015
University of Health Sciences Vientiane
2015
National Institute of Public Health
2015
Asociación entre disminución de la sensibilidad parasitaria in vitro y respuesta terapéutica en pacientes con Leishmaniasis cutánea tratados el centro dermatológico Federico Lleras Acosta ciudad Bogotá
Japanese encephalitis (JE), a vector-borne viral disease, is endemic to large parts of Asia and the Pacific. An estimated 3 billion people are at risk, JE has recently spread new territories. Vaccination programs, increased living standards, mechanization agriculture key factors in decline incidence this disease Japan South Korea. However, transmission likely increase Bangladesh, Cambodia, Indonesia, Laos, Myanmar, North Korea, Pakistan because population growth, intensified rice farming,...
A major cause of the paucity new starting points for drug discovery is lack interaction between academia and industry. Much global resource in biology present universities, whereas focus medicinal chemistry still largely within Open source discovery, with sharing information, clearly a first step towards overcoming this gap. But interface could especially be bridged through scale-up open physical compounds, which would accelerate finding discovery. The Medicines Malaria Venture Box...
Malaria not only remains a leading cause of morbidity and mortality, but it also impedes socioeconomic development, particularly in sub-Saharan Africa. Rapid unprecedented urbanization, going hand-in-hand with often declining economies, might have profound implications for the epidemiology control malaria, as relative disease burden increases among urban dwellers. Reviewing literature using modeling approach, we find that entomologic inoculation rates cities range from 0 to 54 per year,...
Human-made ecologic transformations have occurred at an unprecedented rate over the past 50 years. Prominent among them are water resource development projects. An estimated 40,000 large dams and 800,000 small been built, 272 million hectares of land currently under irrigation worldwide. The establishment operation projects has had a history facilitating change in frequency transmission dynamics malaria, but analyses these environmental risk factors sparse. Here, we present comprehensive...
Background The treatment and control of schistosomiasis, an often neglected tropical disease that exacerbates poverty, depends on a single drug, praziquantel. large-scale use praziquantel might select for drug-resistant parasites, hence there is need to develop new antischistosomal compounds. Here, we report the antimalarial drug mefloquine possesses promising properties in mice. Methodology/Principal Findings A dose (200 or 400 mg/kg) administered orally mice infected with adult Schistosoma...